Latest Breaking News On - J clin pharmacol - Page 26 : comparemela.com

ESTEVE and KOWA Pharmaceuticals America enter into an Exclusive License and Commercialization Agreement for rights to E-58425 for the potential management of acute pain(1-9) in the United States(8,9) celecoxib and tramadol (8,9) BARCELONA, Spain, May 3, 2021 /PRNewswire/ Esteve Pharmaceuticals (ESTEVE), an international specialty pharmaceutical company devoted to the development and commercialization of innovative products, today announced an agreement with Kowa Pharmaceuticals America, Inc. (KPA) under which ESTEVE has granted KPA exclusive rights to commercialize E-58425 in the United States. E-58425 is an investigational medicinal product under development for the management of acute pain in adults that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate

United statesComunidad autonoma de catalunaBen stakelyJ clin pharmacolDrug administrationPrnewswire esteve pharmaceuticalsKowa pharmaceuticals america incKowa pharmaceuticals americaOpin investigMe steveஒன்றுபட்டது மாநிலங்களில்காமுனிடட தன்னாட்சி டி கடலுள்கோவா மருந்துகள் அமெரிக்கா இன்க்கோவா மருந்துகள் அமெரிக்கா